Home/Filings/4/0001209191-22-026461
4//SEC Filing

Shannon James Samuel 4

Accession 0001209191-22-026461

CIK 0001492426other

Filed

May 1, 8:00 PM ET

Accepted

May 2, 5:57 PM ET

Size

11.0 KB

Accession

0001209191-22-026461

Insider Transaction Report

Form 4
Period: 2022-04-28
Transactions
  • Award

    Restricted Stock Units

    2022-04-28+3,9133,913 total
    From: 2023-04-28Exp: 2023-04-28Ordinary shares (3,913 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2022-04-29+4,22344,568 total(indirect: By Trust)
  • Exercise/Conversion

    Restricted Stock Units

    2022-04-294,2230 total
    From: 2022-04-29Exp: 2022-04-29Ordinary shares (4,223 underlying)
  • Tax Payment

    Ordinary Shares

    2022-04-29$98.56/sh1,658$163,41242,910 total(indirect: By Trust)
Footnotes (1)
  • [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.

Issuer

Horizon Therapeutics Public Ltd Co

CIK 0001492426

Entity typeother

Related Parties

1
  • filerCIK 0001485417

Filing Metadata

Form type
4
Filed
May 1, 8:00 PM ET
Accepted
May 2, 5:57 PM ET
Size
11.0 KB